Temoside Temozolomide – 100 mg, 200 mg Tablets

At a Glance

Generic Name: Temozolomide

Brand Name: Temoside

Strength & Pack Size: 100 mg and 200 mg tablets, 1 pack / 5 tablets for each strength

Dosage Form & Route: Oral tablets for swallowing whole on an empty stomach

Therapeutic Class: Oral alkylating cytotoxic chemotherapy

Primary Indications: High-grade glioma, glioblastoma multiforme and anaplastic astrocytoma according to local protocols

Typical Use in Therapy: Concurrent and adjuvant chemoradiation, and treatment of recurrent high-grade brain tumours under neuro-oncology supervision

Mode of Action: Causes DNA damage in tumour cells through methylation of guanine bases, triggering cell death

Key Benefits: Well-established oral component of glioblastoma treatment that can be delivered at home with careful monitoring

Precautions: Requires close monitoring of blood counts, infection risk, liver function and nausea control

Storage: Store in original blister below 25–30 °C, protected from moisture, heat and children

Product Description

Temoside contains temozolomide, an oral alkylating chemotherapy widely used in the management of high-grade glioma, including glioblastoma multiforme and anaplastic astrocytoma. Temoside 100 mg and Temoside 200 mg tablets are typically combined into individual daily doses as part of a carefully calculated regimen based on body surface area and treatment phase. Because temozolomide is taken by mouth, it offers the practicality of at-home administration, while still functioning as a full cytotoxic component of a neuro-oncology protocol that must be designed and monitored by experienced specialists.

In the standard Stupp protocol for newly diagnosed glioblastoma, temozolomide is used concurrently with radiotherapy and then continued as adjuvant cyclic therapy. Temoside temozolomide tablets fit into these patterns by providing mid- and higher-strength units that can be combined with other temozolomide strengths to reach the exact daily dose. The 1 pack / 5 tabs format is convenient for short cycles or specific dosing blocks, for example a 5-day schedule every 28 days, which is common in high-grade glioma regimens.

Generic Meds Mart supplies Temoside temozolomide tablets in original oncology packaging sourced only from licensed manufacturers and authorised distributors. Each blister strip and outer carton clearly shows the strength, generic name, batch number and expiry date, enabling hospital and clinic pharmacies to verify every pack. Parcels are shipped in neutral outer packaging with no external reference to brain tumour, cancer or chemotherapy, supporting patient privacy. Our role is limited to structured access and logistics; all decisions on whether, when and how to use Temoside temozolomide tablets remain with your neuro-oncology team.

Key Uses

Within the boundaries of local approvals and guidelines, Temoside temozolomide tablets are typically used for:

• Newly diagnosed glioblastoma multiforme, in combination with radiotherapy followed by adjuvant temozolomide cycles.
• Anaplastic astrocytoma and other selected high-grade gliomas, as part of multi-step regimens defined by neuro-oncology protocols.
• Recurrent or progressive high-grade glioma, where temozolomide may be used again or in adjusted schedules when clinically appropriate.

The precise indication, daily dose, cycle length and total number of cycles for Temoside 100 mg and 200 mg tablets are always determined by specialists who integrate imaging, histology, performance status and prior treatment history into the overall plan.

How Temozolomide Works in Chemotherapy

Temozolomide, the active ingredient in Temoside tablets, is an oral alkylating agent that exerts its anti-tumour effect by damaging DNA in rapidly dividing cells. After administration, temozolomide undergoes spontaneous conversion at physiological pH to an active compound that methylates DNA, particularly at the O6 and N7 positions of guanine. This methylation leads to mispairing during replication and triggers mismatch repair pathways that, when overwhelmed, result in apoptosis or cell death.

High-grade gliomas, including glioblastoma multiforme, are often infiltrative and difficult to control with surgery alone. By delivering temozolomide systemically, Temoside tablets help target malignant cells that remain after surgery and radiotherapy, as well as microscopic disease within the brain. The degree of benefit may be influenced by tumour molecular features such as MGMT promoter methylation status, which your care team may discuss when planning therapy. Temozolomide is not a cure for glioblastoma, but for many patients it provides improved survival and better disease control compared to radiotherapy alone.

Dosage & Administration

Temoside 100 mg and 200 mg tablets must only be prescribed and monitored by physicians experienced in neuro-oncology and chemotherapy. The total daily dose of temozolomide is usually calculated based on body surface area (mg/m²) and may vary between the concurrent chemoradiation phase and the adjuvant phase. Tablets of different strengths are combined to reach the exact daily dose, and schedules often use five consecutive days of dosing in a 28-day cycle during adjuvant therapy.

Temoside temozolomide tablets are typically taken once daily on an empty stomach, at least one hour before or two hours after food, with a glass of water. Tablets should be swallowed whole and not opened, crushed or chewed because the contents are cytotoxic. Antiemetic medications are commonly prescribed before each dose to help prevent nausea and vomiting. If vomiting occurs after a dose, patients should follow the instructions from their treatment centre and should not repeat the dose unless told to do so. All dose modifications, skipped doses and schedule changes must be directed by the oncology team.

Precautions

Before and during treatment with Temoside temozolomide tablets, careful monitoring is essential. Full blood counts are checked regularly to assess for neutropenia, thrombocytopenia and anaemia, with dose delays or reductions implemented if counts fall below protocol thresholds. Because temozolomide can suppress bone marrow, there is an increased risk of infections, including serious or opportunistic infections, and prophylactic measures such as Pneumocystis jirovecii pneumonia prophylaxis may be considered in some regimens.

Liver function tests are monitored for evidence of hepatotoxicity, and kidney function is also reviewed, especially in patients with comorbidities or concomitant medications. Patients should inform their team about any other medicines or supplements they are taking, since some drugs may influence bone marrow function, bleeding risk or nausea control. Temozolomide can harm an unborn baby, and effective contraception is recommended for both male and female patients during treatment and for a period after the last dose. Breastfeeding is generally not recommended while on Temoside temozolomide tablets.

Temozolomide Side Effects

Common side effects

Common temozolomide side effects reported with Temoside include nausea, vomiting, loss of appetite, fatigue, constipation, headache, hair thinning, mild rash, mild liver enzyme elevations and lowered blood counts such as neutropenia and thrombocytopenia. Many patients also experience general weakness or “flu-like” symptoms during or shortly after the 5-day dosing period.

These common temozolomide side effects can often be managed with pre-emptive antiemetics, adequate hydration, simple dietary adjustments, rest and supportive medications such as laxatives or pain relief as advised by the care team. Regular blood tests help the oncology team pick up falling blood counts early so doses can be adjusted and infections can be prevented or treated promptly. Patients should keep a record of symptoms between cycles and share this with their treating team.

Serious side effects

Serious temozolomide adverse effects require urgent evaluation and may include severe or prolonged neutropenia, febrile neutropenia, severe thrombocytopenia with bleeding, severe liver injury, serious opportunistic infections such as Pneumocystis pneumonia and rare secondary malignancies of the bone marrow. Warning signs such as high fever, chills, persistent cough, shortness of breath, easy bruising, nosebleeds, black or bloody stools, severe abdominal pain, yellowing of the skin or eyes and profound weakness should never be ignored.

If any of these symptoms occur while taking Temoside temozolomide tablets, emergency medical assessment is essential. The oncology team may need to stop or delay further doses, provide antibiotics, transfusions or other intensive supportive measures and reassess the overall chemotherapy strategy.

Storage

Temoside 100 mg and 200 mg temozolomide tablets should be stored in their original blister or bottle at the temperature specified in the package leaflet, generally below 25–30 °C, protected from moisture and direct heat. The pack should remain tightly closed when not in use and kept out of the sight and reach of children. Since temozolomide is cytotoxic, carers should follow local guidance for handling, including washing hands after touching the blister and avoiding contact with damaged tablets. Unused or expired Temoside tablets should be returned to a pharmacy or disposed of according to local cytotoxic waste procedures, not in household rubbish.

Why Buy from Generic Meds Mart

Generic Meds Mart focuses on structured access to essential oncology medicines such as Temoside temozolomide tablets. We work only with licensed manufacturers and authorised distributors who maintain Good Manufacturing Practice standards and provide full batch traceability. Each Temoside 100 mg and Temoside 200 mg pack is supplied in original sealed packaging so hospital and clinic pharmacies can verify authenticity, strength, batch number and expiry date.

Transparent USD pricing helps patients and institutions plan for multiple cycles of temozolomide, which may extend over several months of treatment. Neutral outer packaging and trackable international shipping, where regulations allow, support privacy and make it easier to coordinate deliveries with appointments and treatment schedules. Our role is strictly limited to access and logistics; all clinical aspects of temozolomide therapy remain under the control of your treating neuro-oncology team.

Order Now

Temoside temozolomide tablets are potent oral chemotherapy for high-grade glioma and must never be used without a personalised treatment plan from an experienced oncology service. Before arranging supply through Generic Meds Mart, ensure that your diagnosis has been confirmed, imaging and histology have been reviewed, and your team has decided on a temozolomide-based regimen including dose, number of cycles and monitoring schedule.

Once this plan is in place, your clinic or designated purchaser can calculate how many Temoside 100 mg and Temoside 200 mg packs (1 pack / 5 tabs) are required for the planned cycles, including any expected dose escalations or reductions. The necessary strengths and pack counts can then be selected on Generic Meds Mart, added to the cart and ordered through secure checkout in USD. Medicines will be dispatched in discreet packaging with original oncology labelling inside. Patients should never change, restart or stop temozolomide without explicit instructions from their neuro-oncology team.

FAQ about Temoside (Temozolomide)

Q1: What is Temoside used for?
Temoside contains temozolomide, an oral alkylating chemotherapy used mainly for high-grade glioma, including glioblastoma multiforme and anaplastic astrocytoma, in newly diagnosed and recurrent settings as part of structured neuro-oncology protocols.

Q2: Is Temoside a tablet or a capsule?
Temoside temozolomide in this presentation is supplied as oral tablets (1 pack / 5 tabs per strength). They are swallowed whole with water on an empty stomach and must not be opened, crushed or chewed because the contents are cytotoxic.

Q3: How long will I be on Temoside?
The length of treatment with Temoside temozolomide tablets varies depending on diagnosis, response and tolerance. Many glioblastoma protocols include a concurrent phase with radiotherapy followed by several adjuvant 28-day cycles. Your neuro-oncology team will explain how many cycles are planned initially and how this may change based on MRI scans, blood tests and side effects.

Q4: Will I lose my hair on temozolomide?
Temozolomide can sometimes cause hair thinning, but many patients experience much less hair loss than with some other chemotherapies. Because radiotherapy to the brain can also affect hair, your overall pattern of hair loss may be influenced by both treatments. Your team can advise what to expect in your specific regimen.

Q5: What monitoring will I need while taking Temoside?
Patients on Temoside temozolomide tablets usually require frequent blood tests to monitor white cells, neutrophils, platelets and haemoglobin, as well as liver function and, when relevant, kidney function. You will also be monitored for signs of infection, bleeding, severe fatigue or neurological changes, and regular brain imaging will be scheduled to assess treatment response and disease status.

Soranib 200 mg Tablets – 1 pack / 120 tabs, 1 pack / 30 tabs

At a Glance

Generic Name: Sorafenib

Brand Name: Soranib

Strength & Pack Options: 200 mg tablets; 1 pack / 120 tabs and 1 pack / 30 tabs

Dosage Form: Film-coated oral tablets

Therapeutic Class: Multikinase inhibitor, targeted anticancer therapy

Main Indications: Advanced hepatocellular carcinoma, advanced renal cell carcinoma and differentiated thyroid carcinoma as indicated

Use in Therapy: Systemic oral treatment for unresectable or metastatic disease as per specialist guidance

Prescription Status: Prescription-only oncology medicine

Supplied By: Licensed manufacturers and authorised distributors

Storage: Store below 25 °C in a dry, protected place away from moisture and light

Product Description

Soranib 200 mg contains sorafenib, a targeted multikinase inhibitor used in the systemic treatment of certain advanced solid tumours.
Many liver, kidney and thyroid cancers rely on signalling pathways that control cell growth and blood vessel formation.
By blocking specific kinases within these pathways, Soranib sorafenib tablets help slow tumour progression in patients with unresectable or metastatic disease.

The Soranib 200 mg tablet is widely recognised as a generic sorafenib 200 mg option.
At Generic Meds Mart, Soranib is offered as a variable product with two convenient pack sizes:
1 pack / 120 tablets and 1 pack / 30 tablets. This flexibility allows your oncologist and pharmacist to match the pack size with treatment duration,
follow-up intervals and budget in USD.

In practice, sorafenib is used for unresectable or metastatic hepatocellular carcinoma (HCC), advanced renal cell carcinoma (RCC)
and certain forms of differentiated thyroid carcinoma that are refractory to radioactive iodine.
Soranib 200 mg sorafenib tablets provide the same active ingredient and strength as originator sorafenib while offering an accessible generic alternative for long courses of therapy.

The 120-tablet pack is often suitable for roughly one and a half to two months of treatment, depending on the prescribed daily dose, whereas the
30-tablet pack can be used for shorter cycles, treatment initiation, dose adjustments or smaller, more frequent purchases.
Regardless of pack size, Soranib 200 mg must always be used exactly as directed by an experienced oncologist.
Generic Meds Mart does not initiate or modify cancer treatment; our role is to provide reliable access to generic sorafenib tablets that match your written treatment plan.

Key Uses

Soranib 200 mg (sorafenib) tablets are generally used for the following indications under specialist supervision:

• Unresectable or metastatic hepatocellular carcinoma (advanced liver cancer)
• Advanced renal cell carcinoma (kidney cancer) according to current guidelines
• Progressive, differentiated thyroid carcinoma that is refractory to radioactive iodine

Your oncology team will decide whether Soranib 200 mg is appropriate and how it fits within your overall systemic therapy plan.

How Sorafenib Works in Chemotherapy

Sorafenib is an oral targeted anticancer agent and a multikinase inhibitor.
It is frequently grouped with modern systemic chemotherapy and targeted therapies for liver, kidney and thyroid cancer, although its mechanism differs from classic cytotoxic drugs.

Soranib sorafenib tablets inhibit several intracellular and cell-surface kinases, including RAF kinases and receptors in the
VEGFR and PDGFR pathways. These kinases promote tumour cell proliferation and tumour angiogenesis (new blood vessel formation).
By blocking these targets, Soranib 200 mg exerts both antiproliferative and anti-angiogenic effects, which can slow tumour growth and reduce blood supply to the tumour.

This dual mechanism may help stabilise disease and prolong progression-free survival in selected patients with advanced HCC, RCC or thyroid cancer.
Because these pathways are also present in normal tissues, sorafenib therapy can cause systemic side effects, making careful monitoring by an experienced oncologist essential.

Dosage & Administration

Soranib 200 mg sorafenib tablets must always be taken exactly as prescribed by your oncology team.
The total daily dose, treatment schedule and any dose modifications are based on your diagnosis, body weight, organ function, other medicines and side-effect profile.

• A commonly used starting dose is 400 mg twice daily (two 200 mg Soranib tablets in the morning and two in the evening), unless your doctor advises otherwise.
• Take tablets by mouth with water, with or without food, following your doctor’s specific instructions about meals.
• Swallow Soranib tablets whole; do not crush, split or chew them unless a pharmacist gives specific handling advice.
• Take doses at approximately the same times each day to maintain consistent sorafenib exposure.
• If you miss a dose, follow the written guidance from your treatment centre; do not double your next dose unless your doctor specifically instructs you to.

Your oncologist may adjust or temporarily interrupt Soranib 200 mg therapy if you experience significant side effects or abnormal laboratory results.

Precautions

Before starting Soranib 200 mg, tell your healthcare team about your full medical history and all medicines, supplements and herbal products you use. Key precautions include:

• Pre-existing liver disease, cirrhosis, viral hepatitis or abnormal liver function tests
• History of cardiovascular disease, coronary artery disease, arrhythmias, heart failure or uncontrolled hypertension
• Recent major surgery or planned operations, due to possible effects on wound healing
• History of bleeding disorders, gastrointestinal ulcers, varices or previous significant haemorrhage
• Use of anticoagulants or antiplatelet medicines that may increase bleeding risk
• Concomitant use of strong inducers or inhibitors of drug-metabolising enzymes that may alter sorafenib levels
• Pregnancy or breastfeeding; sorafenib tablets are not recommended and may harm an unborn baby

Men and women of reproductive potential are usually advised to use reliable contraception during and for a period after Soranib sorafenib treatment, as directed by their oncologist.

Sorafenib Side Effects

Common side effects

Many patients experience side effects when they first start Soranib 200 mg. Common adverse reactions may include:

• Hand–foot skin reaction (redness, pain, thickening or blistering on palms and soles)
• Skin rash, dryness or peeling
• Diarrhea or loose stools
• Fatigue, low energy or asthenia
• Nausea, occasional vomiting or reduced appetite
• Weight loss over time
• Hair thinning or alopecia
• Mild to moderate increases in blood pressure

These effects are often manageable with supportive measures, topical treatments, dose reductions or temporary interruptions as decided by your oncology team.

Serious side effects

Less common but serious side effects of sorafenib require urgent medical attention. These may include:

• Severe hypertension or hypertensive crisis
• Chest pain, shortness of breath or signs of heart ischaemia
• Significant bleeding, such as black or bloody stools, coughing or vomiting blood
• Signs of serious liver injury: yellowing of the skin or eyes, dark urine, pale stools, intense upper abdominal pain
• Gastrointestinal perforation or severe, persistent abdominal pain
• Severe skin reactions, blistering or mucosal involvement
• Sudden severe headache, visual changes or neurological symptoms suggestive of a vascular event

If you experience any of these serious symptoms while taking Soranib 200 mg sorafenib tablets, seek emergency medical care immediately and contact your oncology team without delay.

Storage

• Store Soranib 200 mg tablets at room temperature, preferably below 25 °C.
• Keep tablets in their original blisters and outer carton to protect them from moisture and light.
• Keep all anticancer medicines out of the sight and reach of children and pets.
• Do not use after the expiry date printed on the packaging.

Ask your pharmacist how to safely dispose of unused or expired Soranib sorafenib tablets; do not throw them into household waste or wastewater.

Why Buy from Generic Meds Mart

Generic Meds Mart is dedicated to providing safe access to key oncology medicines such as
Soranib 200 mg sorafenib tablets at transparent prices in USD.
We source only from licensed manufacturers and authorised distributors that comply with recognised GMP standards and maintain a reliable export record.

When you buy Soranib 200 mg online from Generic Meds Mart, you benefit from:

• Flexible pack sizes (30 and 120 tablets) that reflect real clinical usage
• Discreet, plain outer packaging for international delivery
• Tracked shipping options to many destinations
• Clear, structured product information to support discussions with your oncology team
• Customer support to help with ordering, payment and delivery questions

Order Now

Soranib 200 mg sorafenib tablets are prescription-only targeted anticancer medicines and must be used strictly under specialist supervision.
Before you order Soranib online, ensure your oncologist has confirmed sorafenib as part of your treatment plan and specified the daily dose and intended duration.

Select the appropriate pack size – Soranib 200 mg 1 pack / 120 tabs or 1 pack / 30 tabs – add it to your cart and complete the secure checkout on Generic Meds Mart.
Your order will be processed, packed discreetly and shipped with tracking where available. Treatment decisions and dose adjustments must always remain with your healthcare team.

Dasatrue Dasatinib Tablets 50 mg / 70 mg (1 pack / 60 tabs)

At a Glance

Generic Name: Dasatinib

Brand Name: Dasatrue

Strength & Pack Size: 50 mg or 70 mg per tablet; 1 pack / 60 tablets

Dosage Form & Route: Oral tablet, swallowed whole with water

Therapeutic Class: Tyrosine kinase inhibitor (TKI), BCR-ABL inhibitor (targeted anticancer therapy)

Primary Indication: Chronic myeloid leukemia (CML) and Philadelphia chromosome–positive acute lymphoblastic leukemia (Ph+ ALL) where dasatinib is appropriate

Typical Use in Therapy: Used within a hematology–oncology plan with response monitoring and blood tests

Prescription Status: Prescription-only medicine

Storage: Store in original packaging as directed; protect from moisture and keep out of reach of children

Product Description

Dasatrue contains dasatinib, a targeted oral tyrosine kinase inhibitor used in CML and Ph+ ALL when a qualified hematology–oncology specialist determines it is appropriate. Dasatrue is supplied as dasatinib tablets in two strengths (50 mg and 70 mg), with this listing covering 1 pack / 60 tablets per selected strength. If you plan to buy Dasatrue online, match the strength to your prescription and monitoring plan rather than choosing based only on price or availability.

In Philadelphia chromosome–positive leukemias, the abnormal BCR-ABL signal is a key driver of malignant cell growth. Dasatinib targets this pathway as a second-generation TKI, and treatment decisions are individualized based on disease phase, prior therapies, response goals, tolerability, and interaction risks. Patients are usually followed with scheduled blood counts and response assessments, and dose changes are made only by the treating team. Dasatrue is prescription-only and should not be started, stopped, or adjusted without specialist supervision.

Generic Meds Mart supplies Dasatrue dasatinib tablets in original manufacturer packaging sourced through licensed channels. Packs typically show the product name, selected strength, active ingredient, batch number, and expiry date to support pharmacy verification on receipt. Orders are shipped in discreet outer packaging, and delivery wording is kept practical (global delivery / international delivery / worldwide delivery) so patients and clinics can coordinate refills with planned monitoring.

Key Uses

Dasatrue (dasatinib) is used for CML and Ph+ ALL when BCR-ABL tyrosine kinase inhibition is clinically appropriate. These conditions require specialist-led monitoring because both efficacy and safety depend on individualized dosing, response checks, and early recognition of complications such as cytopenias or fluid-related effects. Your hematology team defines the treatment goals, what response milestones are expected, and what follow-up schedule is required.

Common Searches and Treatment Contexts for Dasatinib

• Generic Sprycel (Dasatinib): Dasatrue is a therapeutically equivalent generic version of the brand-name drug Sprycel, containing the same active ingredient (dasatinib 50 mg or dasatinib 70 mg) for the treatment of CML and Ph+ ALL.
• BCR-ABL TKI for CML: Dasatinib is a potent second-generation tyrosine kinase inhibitor that targets the BCR-ABL protein, a key driver in Philadelphia chromosome–positive leukemias.
• Dasatinib 50 mg Tablets / Dasatinib 70 mg Tablets: These strengths are used within individualized regimens prescribed by a hematology specialist based on response and tolerability.
• Buy Dasatinib Online: Patients with a confirmed prescription and monitoring plan may seek reliable access to original-packaging dasatinib to maintain therapy continuity.

How Dasatinib Works in Chemotherapy

Dasatinib inhibits tyrosine kinases involved in leukemia cell signaling, including BCR-ABL. In Ph+ disease, BCR-ABL signaling promotes uncontrolled growth and survival of malignant cells. By blocking these signals, dasatinib reduces downstream pathways that cancer cells rely on, supporting disease control when taken consistently as prescribed within a specialist-managed plan.

Because dasatinib is targeted therapy rather than classic cytotoxic chemotherapy, the side-effect profile differs, but monitoring remains essential. Your specialist may monitor blood counts, infection signs, bleeding risk, and symptoms suggestive of fluid accumulation. Treatment decisions should always be made with your hematology team, especially if you take other medicines that may interact.

Dosage & Administration

Dasatrue tablets must be taken exactly as prescribed by your hematology–oncology specialist. Dasatinib dosage is individualized and may be adjusted based on disease phase, treatment response, tolerability, and interacting medicines. Swallow tablets whole with water and follow the schedule provided by your clinic. If you miss a dose, follow your clinic’s instructions rather than taking extra tablets to compensate.

Interactions can be clinically important with dasatinib. Always share a complete list of prescription medicines, over-the-counter products, and supplements with your specialist and pharmacist before starting therapy and before adding anything new. Never stop or change dosing without medical advice, because continuity and monitoring are core parts of safe targeted treatment.

Precautions

Dasatinib can affect blood counts, increasing infection and bleeding risk. Seek medical advice urgently for fever, chills, unusual bruising, prolonged bleeding, black stools, or severe fatigue. Fluid-related effects such as pleural effusion may occur in some patients and can present as cough, chest discomfort, or shortness of breath; new or worsening breathing symptoms should be assessed promptly.

Your specialist will also consider other risk factors and may recommend specific monitoring based on your situation. Pregnancy should be avoided during anticancer therapy, and contraception planning should be discussed with a qualified healthcare professional.

Dasatinib Side Effects

Common side effects

Common dasatinib side effects may include diarrhea, nausea, fatigue, headache, muscle or joint aches, mild rash, and laboratory changes in blood counts. Many effects can be managed within a specialist-led plan, but persistent or worsening symptoms should be discussed with your care team rather than managed by changing the dose independently.

Serious side effects

Serious side effects require urgent medical attention and may include major bleeding, severe or recurrent infections, significant reductions in blood counts, or clinically important fluid accumulation around the lungs. If you develop high fever, heavy bleeding, black stools, chest pain, fainting, or rapidly worsening shortness of breath, seek urgent care and tell clinicians you are taking dasatinib.

Storage

Store Dasatrue in the original packaging as directed on the label, protect from moisture and excessive heat, and keep out of reach of children. Do not use after the expiry date on the carton or blister/bottle. Follow any clinic-specific handling instructions provided for oncology medicines.

Why Buy from Generic Meds Mart

Generic Meds Mart supports access and logistics for specialty medicines such as Dasatrue dasatinib tablets. Products are supplied in original packaging from licensed channels with batch and expiry information for verification. Pricing is displayed in USD, checkout is secure, and shipments are packed in discreet outer cartons to protect privacy.

For patients managing CML or Ph+ ALL within a monitoring plan, reliable access can support therapy continuity. Global delivery options and tracking can help align refills with blood tests and specialist visits. Generic Meds Mart does not replace your treating doctor, and all clinical decisions about dasatinib therapy, including monitoring and side-effect management, must be made by qualified healthcare professionals.

Order Now

Before you order Dasatrue, you should have a confirmed diagnosis of CML or Ph+ ALL and a treatment plan agreed with your hematology–oncology specialist. Your care team will explain which monitoring tests are required and how often, and they will review interaction risks with your current medicines. Once your plan is confirmed, select the correct strength (Dasatrue 50 mg or Dasatrue 70 mg), add 1 pack / 60 tablets to your cart, and complete checkout in USD.

Do not start therapy on your own, and do not stop or change dosing without medical guidance. If you develop concerning symptoms such as heavy bleeding, high fever, chest pain, or worsening shortness of breath, seek urgent medical care and inform clinicians that you are taking dasatinib.

FAQ about Dasatrue (Dasatinib)

Q1: What is Dasatrue used for?
Dasatrue contains dasatinib, a targeted tyrosine kinase inhibitor used in CML and Ph+ ALL when prescribed by a hematology–oncology specialist as part of a complete treatment plan.

Q2: Is Dasatrue a chemotherapy medicine or targeted therapy?
Dasatrue (dasatinib) is targeted therapy that inhibits BCR-ABL and related kinases in Philadelphia chromosome–positive disease. It still requires specialist supervision and monitoring.

Q3: How should I take Dasatrue tablets?
Take Dasatrue exactly as prescribed. Swallow tablets whole with water and follow your specialist’s schedule and monitoring instructions.

Q4: What should I know about dasatinib dosage and missed doses?
Dasatinib dosage is individualized by your specialist. If you miss a dose, follow your clinic’s instructions and do not take extra tablets unless your specialist tells you to.

Q5: What are common dasatinib side effects to monitor?
Common dasatinib side effects can include diarrhea, fatigue, rash, and changes in blood counts. Report persistent or severe symptoms so your care team can advise safely.

Q6: Is Dasatrue 50 mg or 70 mg the same as Sprycel (Generic Sprycel)?
Dasatrue is Generic Sprycel — it contains the same active ingredient (dasatinib) as Sprycel. It’s used for the same indication at the same strength, while differences may be in manufacturer, inactive ingredients (excipients), tablet appearance, and packaging. If you’re switching between products, confirm the substitution with a qualified healthcare professional.

Cytotam 10 mg and 20 mg Tamoxifen Tablets (1 pack / 10 tabs)

At a Glance

Generic Name: Tamoxifen Citrate

Brand Name: Cytotam

Strength & Pack Size: 10 mg and 20 mg tamoxifen tablets, 1 pack / 10 tablets each strength

Dosage Form & Route: Oral film-coated tablets taken by mouth

Therapeutic Class: Selective estrogen receptor modulator (SERM) hormonal therapy

Primary Indications: Hormone receptor–positive breast cancer treatment and breast cancer risk reduction in high-risk women

Usual Adult Dose: Often 20 mg tamoxifen daily or as directed by an oncologist

Mode of Action: Blocks estrogen receptors in breast tissue to reduce estrogen-driven tumour growth

Key Benefits: Proven survival benefit and recurrence risk reduction in ER-positive breast cancer

Precautions: Risk of thrombosis, endometrial changes and hepatic effects; regular monitoring recommended

Storage: Store below 25 °C in a dry place, away from light and out of reach of children

Product Description

Cytotam is a tamoxifen-based oral hormonal therapy used in the management of hormone receptor–positive breast cancer and in carefully selected breast cancer risk-reduction settings. Each pack of Cytotam tablets contains 10 mg or 20 mg tamoxifen citrate, with 1 pack holding 10 tablets at the stated strength. By offering both 10 mg and 20 mg strengths, Cytotam tamoxifen allows oncology teams to prescribe a standard once-daily tamoxifen dose or to tailor lower or split-dose regimens according to the patient’s clinical profile, tolerability and local guideline recommendations.

Tamoxifen has been a fundamental part of breast cancer treatment for many years, particularly for premenopausal and some perimenopausal or postmenopausal women whose tumours express estrogen receptors. In the adjuvant setting, tamoxifen therapy is often prescribed for several years after surgery, chemotherapy or radiotherapy to reduce the risk of recurrence and improve long-term outcomes. In certain high-risk women without diagnosed cancer, tamoxifen may be used as a preventive option when the potential benefit of reducing breast cancer risk outweighs the risks of therapy, always under specialist assessment.

Generic Meds Mart supplies Cytotam 10 mg and 20 mg tamoxifen tablets in original manufacturer packaging sourced from licensed pharmaceutical distributors. Each carton and blister clearly shows the brand name, strength, generic name, tablet count, batch number, expiry date and storage instructions so that patients and clinics can verify the product against oncology prescriptions. All orders are dispatched in discreet outer packaging that does not mention breast cancer, tamoxifen or oncology, which helps maintain privacy while still allowing traceability and documentation for your treatment records. Our role is to support medicine access and logistics, while all treatment decisions remain with your oncology team.

Key Uses

Cytotam tamoxifen tablets are primarily used in hormone receptor–positive breast cancer. Typical uses include adjuvant therapy after surgery and other systemic treatments to lower the risk of local or distant recurrence, management of advanced or metastatic hormone receptor–positive breast cancer as part of endocrine treatment strategies and, in some regions, breast cancer risk reduction in women at substantially increased risk based on family history or genetic factors.

The decision to use Cytotam, the choice between 10 mg and 20 mg tamoxifen doses and the total duration of tamoxifen therapy all depend on a detailed assessment by a breast cancer specialist. Factors considered include menopausal status, tumour receptor profile, previous or concurrent therapies, risk of thrombosis, endometrial history, liver health and individual preferences. Cytotam tamoxifen is not suitable for every patient; it is reserved for women and men whose clinical situation and risk–benefit profile make tamoxifen-based endocrine therapy appropriate.

How Tamoxifen Works in Chemotherapy

Tamoxifen, the active ingredient in Cytotam tablets, is a selective estrogen receptor modulator rather than a traditional cytotoxic chemotherapy agent, but it forms part of many systemic breast cancer treatment plans. Tamoxifen binds to estrogen receptors in breast tissue and acts primarily as an anti-estrogen in this setting, blocking the binding of natural estrogen and reducing estrogen-driven signalling that supports the growth and survival of hormone receptor–positive tumour cells.

By occupying the estrogen receptor, tamoxifen alters gene expression patterns in breast cancer cells, slowing their proliferation and increasing the likelihood of tumour cell death over time. In other tissues, tamoxifen has partial estrogen-like effects, which explains both some of its benefits (such as effects on bone) and some of its risks (including potential endometrial changes). Cytotam tamoxifen tablets are therefore considered endocrine or hormonal therapy within the broader breast cancer treatment pathway and are used in carefully monitored long-term regimens.

Dosage & Administration

Cytotam tamoxifen dosage and schedule must always be determined by an oncologist or breast cancer specialist. A commonly used regimen is 20 mg tamoxifen once daily, taken at approximately the same time each day with or without food. In some cases, 10 mg Cytotam tablets may be used to start at a lower daily dose, to split the total daily dose into two intakes or to support gradual dose adjustments in response to side effects, co-medications or changes in health status.

Cytotam tablets should be swallowed whole with water and not crushed or chewed unless your doctor or pharmacist specifically advises otherwise. Tamoxifen therapy is often continued for several years in the adjuvant setting, with periodic reviews to reassess benefit and tolerability. It is important not to stop Cytotam suddenly or change the dose without medical advice; any concerns about side effects or interactions should be discussed with your treating team, who can decide whether dose modifications or alternative endocrine strategies are appropriate.

Precautions

Before starting Cytotam tamoxifen, your oncology team will review your personal and family history of blood clots, stroke, cardiovascular disease and endometrial or other gynecological conditions. Tamoxifen can increase the risk of venous thromboembolism, including deep vein thrombosis and pulmonary embolism, particularly in patients with existing risk factors or during periods of immobility or surgery. For this reason, it is important to inform your doctors about upcoming operations, long flights or prolonged immobilisation.

Tamoxifen may also affect the endometrium (lining of the uterus), and women with a uterus are usually advised to report any abnormal vaginal bleeding, spotting or pelvic pain promptly. Periodic gynecological assessments may be recommended during long-term therapy. Liver function should be monitored periodically, especially in patients with pre-existing hepatic conditions or those taking other hepatotoxic medicines. Cytotam is generally not recommended during pregnancy or breastfeeding; reliable contraception and careful planning are required if pregnancy is being considered, and any potential use in this context must be overseen by specialists.

Tamoxifen Side Effects

Common side effects

Common tamoxifen side effects include hot flushes, night sweats, mild mood changes, vaginal discharge or dryness, irregular menstrual periods in premenopausal women, fatigue and occasional nausea. Some patients notice leg cramps, mild fluid retention or weight changes. These effects are often manageable with lifestyle adjustments, simple supportive medicines and reassurance, and many people find that symptoms improve over time as the body adapts to tamoxifen therapy.

Serious side effects

More serious tamoxifen adverse effects, while less common, require urgent medical attention. These include symptoms of blood clots such as sudden leg swelling, redness or pain in the calf or thigh, chest pain, sudden shortness of breath or coughing up blood. Endometrial changes can present as unexpected vaginal bleeding, especially after menopause, or persistent pelvic pain. Severe liver problems may cause yellowing of the skin or eyes, dark urine or persistent upper abdominal pain. Sudden neurological symptoms such as weakness on one side, difficulty speaking or severe headache may suggest a stroke and warrant immediate emergency care. Any such symptoms while taking Cytotam tamoxifen should be treated as an emergency and promptly discussed with your oncology team.

Storage

Cytotam 10 mg and 20 mg tablets should be stored at room temperature, typically below 25 °C, in a dry place away from direct heat and sunlight. Keep the tablets in their original blister strips and outer carton until use to protect them from moisture and to avoid confusion with other medicines. As with all prescription medicines, Cytotam must be kept out of sight and reach of children and pets. Unused or expired tablets should be returned to a pharmacy or disposed of in line with local guidance rather than thrown into household rubbish or wastewater.

Why Buy from Generic Meds Mart

Generic Meds Mart helps patients and clinics access Cytotam tamoxifen tablets in regions where availability, price or local supply chains may otherwise limit choice. We work only with licensed manufacturers and authorised distributors that comply with recognised quality standards and maintain clear batch and expiry traceability. By supplying Cytotam 10 mg and 20 mg in sealed original packaging, we support patients, pharmacists and clinicians in verifying that the correct brand, strength and batch are being used in each part of an endocrine treatment plan.

All Cytotam orders placed through Generic Meds Mart are processed in USD via secure online checkout, and parcels are prepared in neutral outer packaging that does not reveal the nature of the medicine or the condition being treated. Where supported by our logistics partners, tracked shipping options help you and your care team plan refills in advance, reducing the risk of interruptions in long-term tamoxifen therapy. Our focus is on access and logistics only; decisions about whether Cytotam tamoxifen is appropriate, which strength to use and how long treatment should continue belong entirely to your oncology specialists.

Order Now

Before you buy Cytotam online from Generic Meds Mart, you should have a confirmed diagnosis of hormone receptor–positive breast cancer or a documented high-risk profile where tamoxifen has been recommended, along with a clear treatment plan from your specialist. Your oncologist will specify whether Cytotam 10 mg, Cytotam 20 mg or a combination of both strengths is required, how many tablets you will need per month and how long therapy is expected to continue.

Once this plan is in place, you can select the relevant Cytotam tamoxifen strengths on Generic Meds Mart, add the required number of packs to your cart and complete secure checkout in USD. Cytotam should never be started, stopped or substituted without direct medical advice; any new or worrying symptoms during treatment should be reported promptly to your oncology team. Generic Meds Mart exists to support timely, discreet and verifiable supply of the tamoxifen strengths prescribed for you, while all medical decisions regarding breast cancer management remain with your treating specialists.

FAQ about Cytotam (Tamoxifen)

Q1: How long will I need to take Cytotam tamoxifen?

The recommended duration of tamoxifen therapy varies but is often five years or longer in the adjuvant setting, depending on tumour features, menopausal status and tolerance. Your oncologist will review your response, side effects and evolving evidence over time to decide how long Cytotam tamoxifen should be continued in your specific case.

Q2: Can men with breast cancer use Cytotam?

Yes. Tamoxifen is also used in some men with hormone receptor–positive breast cancer. The decision to prescribe Cytotam, and the exact dose and duration, will be made by a specialist familiar with male breast cancer management, taking into account potential benefits and risks such as thrombotic events.

Q3: Should I avoid certain medicines while taking Cytotam?

Some medicines, including certain antidepressants and other drugs that affect liver enzymes, may interact with tamoxifen and influence its effectiveness or side-effect profile. Always inform your doctors and pharmacist that you are taking Cytotam tamoxifen, and check before starting any new prescription, over-the-counter product or herbal supplement so that potential interactions can be assessed.

Q4: Will Cytotam affect my fertility or future pregnancy plans?

Tamoxifen can affect menstrual cycles and should not be taken during pregnancy because of potential harm to the developing baby. If you wish to have children in the future, discuss fertility preservation and timing of pregnancy with your oncology team before or early in treatment. Effective contraception is usually recommended during Cytotam therapy and for a period after it ends, based on specialist advice.

Q5: Is there a difference between Cytotam and other tamoxifen brands?

Cytotam contains the same active ingredient, tamoxifen citrate, as other tamoxifen brands, but excipients, packaging and manufacturer may differ. Your oncologist or pharmacist may choose a specific brand based on local availability, regulatory approvals and their experience. If your brand is changed, you should let your team know, but most patients can continue tamoxifen therapy without any change in expected effect or monitoring requirements.

Efavir 200 mg and 600 mg Efavirenz Capsules (1 pack / 30 caps each)

At a Glance

Generic Name: Efavirenz

Brand Name: Efavir

Strength & Pack Size: 200 mg and 600 mg capsules; 1 pack / 30 capsules each

Dosage Form & Route: Oral capsules taken by mouth, usually once daily

Therapeutic Class: Non-nucleoside reverse transcriptase inhibitor (NNRTI) antiretroviral

Primary Indication: HIV-1 infection as part of combination antiretroviral therapy

Usual Adult Dose: Commonly 600 mg once daily at bedtime with other antiretrovirals, as directed by an HIV specialist

Prescription Status: Prescription-only antiretroviral medicine

Storage: Store below 25–30 °C, protect from moisture and light, keep out of reach of children

Product Description

Efavir is a branded formulation of efavirenz, a non-nucleoside reverse transcriptase inhibitor used in the treatment of HIV-1 infection. It is not used alone but always as part of combination antiretroviral therapy alongside other antiviral medicines to control the virus, maintain or improve immune function and reduce the risk of HIV-related illnesses. Efavir is available in capsule strengths of 200 mg and 600 mg, each pack containing 30 capsules, allowing prescribers to tailor the dosing regimen to individual patient needs and local guidelines.

The 600 mg strength of Efavir is commonly used for once-daily dosing in adults and adolescents when efavirenz is part of a complete HIV regimen that also includes nucleoside or nucleotide reverse transcriptase inhibitors and sometimes additional agents. The 200 mg strength may be used in step-up dosing, in body-weight–based schedules or in special situations such as dose adjustments for drug interactions, hepatic impairment or paediatric use under specialist supervision. Efavir is generally taken at bedtime to help reduce certain central nervous system side effects associated with efavirenz.

Generic Meds Mart supplies Efavir 200 mg and Efavir 600 mg efavirenz capsules in original manufacturer packaging from licensed distributors. Each pack clearly displays the brand name, strength, generic name, batch number and expiry date so that healthcare providers can verify the product. Orders are dispatched in neutral outer packaging that does not reveal the nature of the contents, supporting privacy for people living with HIV while they access the medicines prescribed by their treating team.

Key Uses

Efavir is used for the treatment of HIV-1 infection in adults and adolescents, always in combination with other antiretroviral medicines. It is not a cure for HIV but helps to suppress viral replication, lowering the amount of virus in the blood (viral load) and supporting recovery or preservation of CD4 immune cells. By maintaining viral suppression and good adherence over the long term, effective antiretroviral therapy reduces the risk of opportunistic infections, HIV-related illnesses and onward transmission.

Efavir-containing regimens may be chosen according to local guidelines, availability and individual patient factors, including prior treatment history, resistance test results, potential drug interactions and co-existing conditions such as tuberculosis, hepatitis or psychiatric illness. The decision to include efavirenz, and the choice between 200 mg and 600 mg capsules, is made by an HIV specialist based on these clinical considerations. Patients should not start, change or stop Efavir or any part of their antiretroviral regimen without professional guidance.

How Efavirenz Works in Antiviral Therapy

Efavirenz, the active ingredient in Efavir capsules, belongs to the class of non-nucleoside reverse transcriptase inhibitors. HIV-1 uses an enzyme called reverse transcriptase to copy its genetic material from RNA into DNA inside infected cells. This step is essential for the virus to integrate into the host genome and produce new virus particles. Efavirenz binds to a specific site on the reverse transcriptase enzyme, causing a change in its shape and interfering with its function.

By allosterically inhibiting reverse transcriptase, efavirenz reduces the ability of HIV to replicate. When used together with other antiretroviral agents that target different stages of the viral life cycle, efavirenz contributes to a potent and durable suppression of viral load. Continuous suppression helps protect the immune system and decreases the risk of resistance mutations emerging. However, maintaining this benefit requires good adherence, meaning that doses of Efavir and companion antiretrovirals are taken as prescribed and not frequently missed.

Dosage & Administration

Efavir dosing and schedule are determined by an HIV specialist. In many adult treatment protocols, efavirenz is given as 600 mg once daily, typically at bedtime, in combination with other antiretroviral medicines. Taking Efavir at night and on an empty stomach or with a light snack may help reduce some central nervous system side effects such as dizziness, abnormal dreams or feeling “spaced out”. Heavier or high-fat meals can increase efavirenz levels and make these effects more pronounced.

The 200 mg capsule strength allows for flexible dosing strategies. It may be used to build up to a full 600 mg dose, to adjust the total daily dose in certain drug interaction scenarios or in weight-based regimens in adolescents when recommended by treatment guidelines. Efavir capsules should be swallowed whole with water and should not be opened or crushed unless a specialist provides specific instructions. Patients should follow the instructions provided by their HIV clinic exactly and should not change the dose or timing without medical advice.

Precautions

Before starting Efavir, your healthcare team will review your medical history, including any liver problems, psychiatric conditions, seizure disorders, heart rhythm issues, pregnancy plans or other significant health concerns. Efavirenz can affect liver function, so baseline and periodic liver enzyme tests are usually recommended, especially in people with hepatitis B or C co-infection. Central nervous system effects, including insomnia, abnormal dreams, dizziness, mood changes or depression, can occur and are sometimes more common in the first weeks of therapy. Patients with a history of severe psychiatric illness should be monitored closely, and any worrying symptoms should be reported promptly.

Efavirenz interacts with many other medicines, including certain antiretrovirals, tuberculosis drugs such as rifampicin, antifungals, some antidepressants, hormonal contraceptives and herbal remedies like St John’s wort. These interactions can alter drug levels and impact safety or effectiveness. It is essential to inform your doctor and pharmacist about all medicines, supplements and traditional or herbal products you use. Efavirenz can reduce the effectiveness of hormonal contraception, so reliable barrier methods or non-hormonal contraception are usually recommended. Pregnancy considerations, including potential risks in early pregnancy, should be discussed in detail with your HIV specialist.

Efavirenz Side Effects

Common side effects

Common side effects of Efavir include dizziness, drowsiness, difficulty concentrating, unusual dreams or nightmares, trouble sleeping, tiredness and a feeling of being “spaced out”, especially soon after starting treatment. Some people also experience rash, mild nausea, stomach discomfort or changes in appetite. These effects are often most noticeable in the first days or weeks of therapy and may lessen with time as the body adjusts. Taking Efavir at bedtime and avoiding high-fat evening meals can sometimes help reduce central nervous system symptoms. If common side effects remain distressing or interfere with daily functioning, you should discuss them with your HIV clinic.

Serious side effects

More serious side effects are less common but require immediate medical attention. These include severe rash or rash with blistering, mouth sores, fever or involvement of the eyes, which can signal serious skin reactions; marked mood changes, deep depression, suicidal thoughts or unusual behaviour; severe liver problems with symptoms such as yellowing of the skin or eyes, dark urine, significant abdominal pain or persistent nausea; and signs of severe allergic reaction such as swelling of the face, lips or tongue with difficulty breathing. Any seizure activity, persistent confusion or signs of severe mental health disturbance while taking Efavir should be treated as urgent. If you experience any of these serious symptoms, seek medical care immediately and inform your HIV specialist.

Storage

Efavir capsules should be stored at room temperature, generally below 25–30 degrees Celsius, in a dry place away from direct heat and moisture. Keep the capsules in their original bottle or blister pack until the time of use to protect them from humidity and mix-ups with other medicines. Do not store Efavir in the bathroom or near sinks. Always keep the medicine out of sight and reach of children and pets. Do not use Efavir after the expiry date printed on the packaging, and consult your pharmacist or clinic about safe disposal of expired or unused capsules.

Why Buy from Generic Meds Mart

Generic Meds Mart is focused on providing reliable access to essential antiretroviral medicines such as Efavir 200 mg and Efavir 600 mg efavirenz capsules. We source Efavir only from licensed manufacturers and authorised distributors who follow appropriate quality and regulatory standards and maintain traceable batch and expiry records. Original packaging is retained so that HIV clinics and pharmacies can verify the product and strength against your treatment plan before dispensing.

Orders through Generic Meds Mart are processed in USD via secure online checkout, and all shipments are prepared in neutral external packaging that does not disclose HIV status or medication type. Where available, tracked delivery options help you and your care team coordinate ongoing therapy and avoid interruptions in supply. While we assist with access and logistics, all decisions regarding regimen choice, dose, monitoring and long-term management of HIV infection remain firmly with your HIV specialist and clinic.

Order Now

Before ordering Efavir 200 mg or 600 mg from Generic Meds Mart, you should have a confirmed diagnosis of HIV-1 infection, a clear treatment plan and a prescription or recommendation from your HIV specialist that specifically includes efavirenz at the appropriate dose. Your clinician will take into account your viral load, CD4 count, resistance profile, co-infections, other medicines and potential pregnancy before deciding if Efavir-based therapy is right for you. Once you have this medical guidance, you can select the correct Efavir strength and quantity to match your regimen and add it to your cart for secure checkout.

You should never start or stop Efavir, change from 200 mg to 600 mg, or alter your dosing schedule without discussing it with your HIV clinic. Missing doses or making unplanned changes to therapy can lead to viral rebound and resistance, which may limit future treatment options. If you experience new symptoms, side effects or difficulties with adherence while taking Efavir, contact your healthcare team promptly for advice rather than adjusting the medicine yourself. Generic Meds Mart exists to support medicine access according to your specialist’s plan, not to replace professional HIV care.

FAQ about Efavir (Efavirenz)

Q1: Is Efavir a complete treatment for HIV?

Efavir is not a complete treatment on its own. It contains efavirenz, an NNRTI that must be used together with other antiretroviral medicines as part of a combination regimen. Your HIV specialist will design a complete treatment plan that includes Efavir with other drugs to suppress the virus effectively and reduce the risk of resistance.

Q2: When is the best time to take Efavir capsules?

Efavir is often taken once daily at bedtime. Taking it at night and avoiding heavy, high-fat meals near the dose may help reduce certain central nervous system side effects such as dizziness, abnormal dreams or feeling “high” or “foggy”. Your clinic will give you specific advice about timing based on your overall regimen and lifestyle.

Q3: Can I drink alcohol while taking Efavir?

Occasional light alcohol use may be allowed for some patients, but alcohol can worsen dizziness, drowsiness and mood changes and may also affect liver health. Because both Efavir and alcohol can impact the liver and the central nervous system, it is important to discuss alcohol use honestly with your HIV specialist, who can advise what is safe in your situation.

Q4: What should I do if I miss a dose of Efavir?

If you forget a dose of Efavir and it has not been very long since your usual time, take it as soon as you remember, then continue with your normal schedule. If it is almost time for your next dose, skip the missed capsule and take the next one at the regular time. Do not double up to make up for a missed dose. Repeated missed doses can increase the risk of resistance, so talk to your clinic if adherence is difficult so they can help you find solutions.

Q5: Can Efavir be used during pregnancy?

The use of efavirenz in pregnancy requires careful consideration. In many settings, safer alternatives may be preferred during early pregnancy, while in others the benefits of continuing an effective regimen may outweigh potential risks. If you are pregnant or planning a pregnancy while taking Efavir, do not stop the medicine on your own, but contact your HIV specialist immediately so that your treatment can be reviewed and, if necessary, adjusted in a controlled way.

Xylutide Enzalutamide – 40 mg (1 pack / 28 capsules)

At a Glance

Brand name: Xylutide

Generic name: Enzalutamide

Active ingredient: Enzalutamide

Strength & pack size: Xylutide 40 mg (1 pack / 28 capsules)

Dosage form: Oral hard capsules

Main indication: Advanced and metastatic castration-resistant prostate cancer and other androgen-driven settings as indicated

Therapeutic class: Androgen receptor inhibitor (hormonal anticancer therapy)

Use in therapy: Systemic oral treatment alongside ongoing androgen deprivation therapy (ADT)

Prescription status: Prescription-only anticancer medicine

Supplied by: Licensed manufacturers and authorised distributors

Storage: Store below 25 °C in a dry place, protected from moisture and light

Product Description

Xylutide 40 mg capsules are a generic enzalutamide medicine used in the treatment of advanced and metastatic
prostate cancer. Enzalutamide is a potent oral androgen receptor inhibitor that blocks androgen-driven signalling
inside prostate cancer cells. Xylutide 40 mg (1 pack / 28 capsules) provides a convenient weekly supply of
enzalutamide 40 mg capsules that matches your specialist’s written treatment plan.

In many protocols, enzalutamide is used for metastatic castration-resistant prostate cancer (mCRPC) and in other settings such as
metastatic castration-sensitive or non-metastatic castration-resistant disease, according to recognised guidelines.
Because Xylutide is a generic enzalutamide product, it contains the same active ingredient as branded enzalutamide while offering more accessible pricing in USD
for long-term hormonal therapy.

A typical adult daily dose is 160 mg, often given as four Xylutide 40 mg capsules once daily, although your oncology or urology team may adjust this.
The pack of Xylutide 40 mg (1 pack / 28 capsules) may correspond to a seven-day supply at 160 mg per day or a longer course at reduced doses.
Treatment with Xylutide enzalutamide is usually combined with continuous androgen deprivation therapy (ADT) using LHRH analogues or after surgical castration.

When you buy Xylutide 40 mg online from Generic Meds Mart, you receive generic enzalutamide capsules supplied by licensed manufacturers and authorised distributors
that comply with recognised GMP standards. Discreet outer packaging protects your privacy, while original blisters and cartons preserve all product details such as strength, batch number and expiry date.

This Xylutide 40 mg enzalutamide product is intended only for patients under specialist oncology or urology care.
Generic Meds Mart does not diagnose cancer or alter treatment plans; the information here supports informed discussions with your treating team about access to
generic enzalutamide capsules.

Key Uses

Xylutide 40 mg enzalutamide capsules are generally used for the following indications under specialist supervision:

• Treatment of metastatic castration-resistant prostate cancer (mCRPC) alongside continuous androgen deprivation therapy
• Treatment of metastatic castration-sensitive or non-metastatic castration-resistant prostate cancer in selected patients according to recognised guidelines
• Continuation or switch therapy in men previously treated with other hormonal agents or chemotherapy when an androgen receptor inhibitor is recommended

Your specialist will determine whether Xylutide 40 mg is appropriate, how it fits into your overall treatment plan and how long
enzalutamide therapy should continue.

How Enzalutamide Works in Chemotherapy

Enzalutamide is an oral hormonal anticancer agent often grouped within modern systemic chemotherapy and targeted hormonal regimens.
Xylutide 40 mg contains enzalutamide, an androgen receptor inhibitor that blocks androgen-driven signalling in
prostate cancer cells.

In androgen-dependent prostate cancer, hormones such as testosterone and dihydrotestosterone bind to androgen receptors, which then move into the cell nucleus and activate genes that promote tumour growth and survival.
Xylutide enzalutamide capsules act at several stages of this process: they bind to the androgen receptor with high affinity, prevent androgen binding, reduce nuclear translocation and limit DNA binding and gene activation.
By disrupting androgen receptor signalling, Xylutide 40 mg can slow tumour growth, lower PSA levels and delay complications of advanced prostate cancer.

Although more targeted than many traditional cytotoxic agents, enzalutamide still has systemic effects and can influence the nervous system, blood pressure and liver function.
Careful monitoring by an experienced oncologist or urologist is therefore essential during Xylutide enzalutamide therapy.

Dosage & Administration

Xylutide 40 mg enzalutamide capsules must always be taken exactly as prescribed by your specialist.
Daily dosing, treatment duration and any dose changes depend on your diagnosis, other medicines and how you tolerate therapy.

• Take Xylutide capsules by mouth once daily, with or without food, at approximately the same time each day.
• Swallow Xylutide 40 mg capsules whole with water; do not open, crush or chew them unless your doctor or pharmacist gives specific instructions.
• Continue concurrent androgen deprivation therapy (ADT) unless your doctor has already performed surgical castration and advised otherwise.
• Do not change your dose, skip doses or stop taking Xylutide without clear guidance from your oncology or urology team.
• If you miss a dose, follow your doctor’s instructions; do not take extra capsules to compensate unless specifically advised.

Your specialist will schedule regular visits, PSA tests, blood pressure checks and other investigations to monitor your response to
Xylutide enzalutamide and to adjust treatment as needed.

Precautions

Before starting Xylutide 40 mg, inform your doctor about your full medical history and all medicines, supplements and herbal products you use. Important considerations include:

• History of seizures, epilepsy, brain injury, stroke or conditions that increase seizure risk
• Cardiovascular disease, high blood pressure, heart failure or rhythm disturbances
• Pre-existing liver impairment or significant hepatic disease
• Previous falls, fractures or conditions affecting bone strength or balance
• Use of strong CYP2C8 or CYP3A4 inhibitors or inducers and medicines with a narrow therapeutic index
• Use of over-the-counter products or herbal remedies that may interact with enzalutamide

Enzalutamide is not intended for use in women and may harm an unborn baby. Men taking Xylutide 40 mg are usually advised to use effective contraception if their partner may become pregnant, both during treatment and for a period afterwards, as directed by their doctor.

Enzalutamide Side Effects

Common side effects

Many patients experience side effects when starting Xylutide enzalutamide capsules, especially during the first months of therapy. Common reactions may include:

• Fatigue, low energy or general tiredness
• Hot flushes
• Increased blood pressure or worsening of existing hypertension
• Headache, dizziness or difficulty concentrating
• Back pain, joint pain or muscle discomfort
• Mild swelling of the hands, ankles or feet
• Mild diarrhea, nausea or reduced appetite

These side effects are often manageable with supportive care or adjustments in overall management, but you should report persistent or troublesome symptoms to your oncology team.

Serious side effects

Some side effects of enzalutamide are less common but serious and require urgent medical attention. Serious reactions may include:

• Seizures, sudden loss of consciousness or unusual movements
• Severe confusion, strong headache or visual changes
• Very high blood pressure, chest pain or shortness of breath suggesting a cardiovascular event
• Signs of severe liver problems, such as yellowing of the skin or eyes, dark urine, pale stools or intense upper abdominal pain
• Repeated falls, new fractures or sudden severe bone pain

If you experience any of these serious symptoms while taking Xylutide 40 mg, seek immediate medical care and contact your specialist as soon as possible.

Storage

• Store Xylutide 40 mg capsules at room temperature, usually below 25 °C, in a dry place away from direct sunlight and excess heat.
• Keep the capsules in their original blisters and carton until use to protect them from moisture and light.
• Keep enzalutamide capsules out of the sight and reach of children and pets.
• Do not use the medicine after the expiry date printed on the packaging.

Ask your pharmacist or follow local regulations for safe disposal of unused or expired Xylutide enzalutamide capsules.

Why Buy from Generic Meds Mart

Generic Meds Mart focuses on providing reliable access to essential oncology medicines such as
Xylutide 40 mg enzalutamide capsules at fair prices in USD.
We work only with licensed manufacturers and authorised distributors that comply with recognised GMP standards and maintain a documented export track record.

When you buy Xylutide 40 mg online from Generic Meds Mart, you benefit from:

• Competitive pricing on generic enzalutamide capsules compared with many local pharmacies
• Discreet, plain packaging designed to protect your privacy during shipping
• Tracked international delivery options to many destinations
• Clear, structured product information to support discussions with your oncologist or urologist
• Customer support available to assist with ordering, payment and shipping questions

Our goal is to help you maintain continuity of prescribed hormonal therapy with transparent conditions and professional handling of each order.

Order Now

Xylutide 40 mg enzalutamide capsules are prescription-only anticancer medicines and must be used strictly under the supervision of an experienced oncologist or urologist.
Before you order Xylutide 40 mg online, ensure that you have a valid prescription or written treatment plan specifying enzalutamide, the daily dose and the intended duration of therapy.

Select Xylutide 40 mg (1 pack / 28 capsules), choose the appropriate quantity, add Xylutide to your cart and complete the secure checkout process.
Your order will be processed, packed discreetly and shipped with tracking where available.

Generic Meds Mart does not provide diagnosis or personalised medical advice. All treatment decisions, dose changes and monitoring remain the responsibility of your healthcare team.

Imatib Imatinib – 100 mg (1 pack / 10 tablets)

At a Glance

Brand name: Imatib

Generic name: Imatinib mesylate

Active ingredient: Imatinib

Strength & pack size: Imatib 100 mg (1 pack / 10 tablets)

Dosage form: Oral film-coated tablets

Main indication: Philadelphia chromosome–positive chronic myeloid leukemia (CML) and selected gastrointestinal stromal tumors (GIST)

Therapeutic class: Tyrosine kinase inhibitor (TKI)

Use in therapy: Targeted systemic treatment for Ph+ CML and indicated solid tumors

Prescription status: Prescription-only anticancer medicine

Supplied by: Licensed manufacturers and authorised distributors

Storage: Store below 25 °C in a dry place, protected from moisture and light

Product Description

Imatib 100 mg tablets are a generic imatinib mesylate medicine used in the treatment of specific blood cancers and solid tumors.
Imatinib is a well-known tyrosine kinase inhibitor (TKI) that has transformed outcomes for patients with
Philadelphia chromosome–positive chronic myeloid leukemia (CML) and certain gastrointestinal stromal tumors (GIST).
Imatib 100 mg (1 pack / 10 tablets) offers a compact pack size that may be used as an initial supply, a short bridging course or as continuation therapy,
always according to your specialist’s prescription.

Each Imatib tablet contains 100 mg of imatinib, taken by mouth, usually once or twice daily depending on the required total daily dose.
The 100 mg strength provides flexibility for dose titration and individualised treatment regimens. Because
Imatib is a generic imatinib product, it contains the same active ingredient as branded imatinib while offering a more accessible price in USD,
which can be important for patients who need long-term imatinib therapy.

When you buy Imatib 100 mg online from Generic Meds Mart, you receive imatinib tablets supplied by licensed manufacturers and authorised distributors
that follow recognised GMP standards. The medicine is shipped in plain, discreet outer packaging, while original blisters and cartons maintain full details such as strength, batch number and expiry date.

This Imatib 100 mg (1 pack / 10 tablets) product is intended only for patients already under the care of a haematologist or oncologist who has recommended
imatinib tablets as part of a treatment plan. Generic Meds Mart does not diagnose conditions or change treatment protocols;
the information on this page is designed to support informed discussions with your specialist about access to generic imatinib.

Key Uses

Imatib 100 mg imatinib tablets are typically used for the following indications under specialist supervision:

• Treatment of Philadelphia chromosome–positive chronic myeloid leukemia (CML) in chronic, accelerated or blast phase as directed
• Treatment of Philadelphia chromosome–positive acute lymphoblastic leukemia (Ph+ ALL) in selected patients
• Treatment of metastatic and/or unresectable gastrointestinal stromal tumors (GIST) expressing KIT (CD117) or other relevant targets
• Treatment of other rare malignancies where imatinib is specifically recommended in recognised oncology guidelines

Your specialist will determine how Imatib 100 mg fits into your therapy, what total daily dose you need and how long
imatinib treatment should continue.

How Imatinib Works in Chemotherapy

Imatinib is a targeted anticancer agent often grouped within modern systemic chemotherapy and targeted therapy regimens.
Imatib 100 mg contains imatinib, a tyrosine kinase inhibitor (TKI) that blocks abnormal signalling from specific tyrosine kinases such as BCR-ABL in CML
and KIT in many GIST tumours.

Imatib imatinib tablets work by binding to these overactive kinases and blocking their ATP-binding sites.
This disrupts the signalling pathways that drive uncontrolled cancer cell growth and survival. In
chronic myeloid leukemia, this targeted inhibition can reduce leukemic cell counts and support long-term disease control.
In GIST, inhibition of KIT may shrink or stabilise tumours that depend on this pathway.

Because imatinib acts as a targeted TKI rather than a traditional cytotoxic drug, its side effect profile differs from standard chemotherapy.
However, Imatib 100 mg is still a potent anticancer medicine that must be monitored carefully by an experienced haematologist or oncologist.

Dosage & Administration

Imatib 100 mg imatinib tablets must always be taken exactly as prescribed by your specialist.
Daily dosing, timing and duration of therapy depend on your diagnosis, disease phase, response and tolerance.

• Take Imatib tablets by mouth with a large glass of water; many patients are advised to take doses with food to reduce stomach discomfort.
• Swallow the tablets whole. Do not crush, split or chew Imatib 100 mg tablets unless your doctor or pharmacist has given specific instructions.
• The total daily dose may be taken once daily or divided into two doses, depending on your prescription and how well you tolerate treatment.
• Do not change your dose or stop taking Imatib without clear instructions from your haematologist or oncologist.
• If you miss a dose, follow your doctor’s advice; do not double the next dose to compensate unless your specialist has recommended it.

Your oncology team will schedule regular blood tests and other assessments to monitor your response to
Imatib imatinib therapy and to guide any necessary dose adjustments.

Precautions

Before starting Imatib 100 mg, inform your doctor about your full medical history and all medicines, supplements or herbal products you use. Important considerations include:

• History of liver disease, kidney impairment or significant cardiac disease
• Pre-existing fluid retention, swelling, heart failure or shortness of breath
• Previous or current gastrointestinal bleeding, ulcers or serious stomach or bowel conditions
• Use of other anticancer medicines, immunosuppressants or biologic therapies
• Use of strong CYP3A4 inhibitors or inducers, certain antibiotics, antifungals or antiepileptics that may interact with imatinib
• Use of paracetamol, anticoagulants or other medicines that may require careful monitoring with Imatib imatinib tablets

Imatinib may not be suitable during pregnancy, and effective contraception is usually recommended during treatment and for a period afterwards, as advised by your doctor.
Breastfeeding is often discouraged while taking Imatib. Your specialist will set an appropriate monitoring schedule in your case.

Imatinib Side Effects

Common side effects

Many patients experience side effects when starting Imatib imatinib tablets, especially during the first months of treatment. Common reactions may include:

• Nausea, mild vomiting or stomach discomfort
• Diarrhea or, in some cases, constipation
• Fluid retention with swelling of ankles, legs or around the eyes
• Muscle cramps, bone pain or joint discomfort
• Fatigue, weakness or general tiredness
• Mild skin rash or itching

These side effects are often manageable with supportive care or dose adjustments, but you should report persistent or troublesome symptoms to your oncology team.

Serious side effects

Some side effects of imatinib are less common but more serious and require urgent medical attention. Serious reactions may include:

• Marked fluid retention with sudden weight gain, worsening shortness of breath or pronounced leg swelling
• Signs of severe liver problems, such as yellowing of the skin or eyes, dark urine, pale stools or intense upper abdominal pain
• Severe abdominal pain, bloody stools or vomiting blood, which may indicate serious gastrointestinal issues
• Significant changes in blood counts, with fever, frequent infections, unusual bruising or prolonged bleeding
• Severe skin reactions, widespread rash, blistering or involvement of the mouth or eyes

If you experience any of these serious symptoms while taking Imatib 100 mg, seek immediate medical care and contact your specialist as soon as possible.

Storage

• Store Imatib 100 mg tablets at room temperature, usually below 25 °C, in a dry place away from direct sunlight and excess heat.
• Keep the tablets in their original blisters and carton until use to protect them from moisture and light.
• Keep Imatib imatinib tablets out of the sight and reach of children and pets.
• Do not use the medicine after the expiry date printed on the packaging.

Ask your pharmacist or follow local regulations for safe disposal of unused or expired imatinib tablets.

Why Buy from Generic Meds Mart

Generic Meds Mart focuses on providing reliable access to essential oncology medicines such as
Imatib 100 mg imatinib tablets at fair prices in USD.
We work only with licensed manufacturers and authorised distributors that comply with recognised GMP standards and maintain a documented export track record.

When you buy Imatib 100 mg online from Generic Meds Mart, you benefit from:

• Competitive pricing on generic imatinib tablets compared with many local pharmacies
• Discreet, plain packaging designed to protect your privacy during shipping
• Tracked international delivery options to many destinations
• Clear, structured product information to support discussions with your haematologist or oncologist
• Customer support available to assist with ordering, payment and shipping questions

Our goal is to help you maintain continuity of prescribed targeted therapy with transparent conditions and professional handling of each order.

Order Now

Imatib 100 mg imatinib tablets are prescription-only anticancer medicines and must be used strictly under the supervision of a haematologist or oncologist.
Before you order Imatib 100 mg online, ensure that you have a valid prescription or written treatment plan specifying imatinib, the required daily dose and intended duration of therapy.

Select Imatib 100 mg (1 pack / 10 tablets), choose the appropriate quantity, add Imatib to your cart and complete the secure checkout process.
Your order will be processed, packed discreetly and shipped with tracking where available.

Generic Meds Mart does not provide diagnosis or personalised medical advice. All treatment decisions, dose changes and monitoring remain the responsibility of your oncology team.

Gefticip Gefitinib – 250 mg (1 pack / 30 tablets)

At a Glance

Generic Name: Gefitinib

Brand Name: Gefticip

Strength & Pack Size: 250 mg tablets – 1 pack / 30 tabs

Dosage Form: Oral film-coated tablets

Therapeutic Class: EGFR tyrosine kinase inhibitor, targeted anticancer therapy

Main Indication: Advanced or metastatic non-small cell lung cancer (NSCLC) with sensitising EGFR mutations

Use in Therapy: First-line or subsequent-line targeted treatment under specialist oncology guidance

Prescription Status: Prescription-only oncology medicine

Supplied By: Licensed manufacturers and authorised distributors

Storage: Store below 25 °C in a dry place, protected from light and moisture

Product Description

Gefticip 250 mg is a gefitinib tablet used as targeted therapy in selected patients with advanced or metastatic
non-small cell lung cancer (NSCLC). Many NSCLC tumours, especially adenocarcinomas, carry activating
EGFR mutations that make tumour cells depend heavily on EGFR signalling for growth and survival.
Gefticip 250 mg gefitinib tablets are designed to inhibit this pathway and help slow disease progression in EGFR-mutation–positive lung cancer
under the supervision of an experienced oncology team.

Each Gefticip tablet contains 250 mg gefitinib, the standard oral dose used in most gefitinib protocols.
The 1 pack / 30 tablets presentation usually corresponds to about one month of once-daily treatment, making it simple to align
Gefticip orders with monthly visits and imaging. As a generic gefitinib 250 mg product, Gefticip offers the same active ingredient and strength
as originator gefitinib while often being more accessible in USD, which is important when targeted therapy is required for many months.

Gefticip 250 mg gefitinib tablets are normally prescribed only after molecular testing has confirmed that the tumour carries a sensitising EGFR mutation.
In some settings, Gefticip is used as first-line systemic therapy in EGFR-positive NSCLC; in others it may be prescribed after chemotherapy, depending on guidelines.
Generic Meds Mart does not decide whether you should receive gefitinib; we supply Gefticip 250 mg in the pack size and quantity that match your written treatment plan.

Key Uses

Gefticip 250 mg gefitinib tablets are typically used under specialist supervision for:

• Advanced or metastatic non-small cell lung cancer (NSCLC), usually adenocarcinoma, with documented sensitising EGFR mutations
• First-line targeted therapy in EGFR-mutation–positive NSCLC where gefitinib is recommended by current guidelines
• Subsequent-line targeted therapy in selected patients whose disease remains suitable for EGFR inhibitor treatment

Your oncologist will decide whether Gefticip 250 mg is appropriate based on EGFR mutation status, prior therapies and overall clinical status.

How Gefitinib Works in Chemotherapy

Gefitinib is a targeted anticancer medicine from the class of EGFR tyrosine kinase inhibitors.
Unlike classic cytotoxic chemotherapy, Gefticip gefitinib does not directly damage DNA.
Instead, it selectively blocks the intracellular tyrosine kinase activity of the epidermal growth factor receptor (EGFR).

In EGFR-positive NSCLC, constitutively active EGFR triggers downstream signalling through pathways such as RAS/RAF/MEK/ERK and PI3K/AKT,
promoting tumour cell survival and proliferation. By binding to the ATP-binding site of the EGFR tyrosine kinase,
Gefticip 250 mg reduces receptor phosphorylation and interrupts these downstream signals.
This deprives tumour cells of proliferative and anti-apoptotic signals, making them more likely to slow growth or undergo programmed cell death.

Because EGFR is also present in normal tissues, especially skin and gastrointestinal epithelium,
gefitinib therapy can lead to class-typical side effects such as rash and diarrhea, which require regular monitoring and supportive care.

Dosage & Administration

The dose and schedule of Gefticip 250 mg must always be set by your oncology team based on current guidelines and your individual situation.
In many protocols, the usual adult dose is one Gefticip 250 mg tablet taken once daily, but only your treating specialists can confirm the correct regimen.

• Take Gefticip tablets once daily at roughly the same time each day, with a glass of water.
• Swallow Gefticip 250 mg whole; do not crush, split or chew the tablet unless your pharmacist provides specific instructions.
• Follow your clinic’s advice on taking gefitinib with or without food and keep a consistent routine.
• Do not change your daily dose, stop treatment or take extra tablets without clear guidance from your oncology team.
• If you miss a dose, follow written instructions from your treatment centre; do not double the next dose unless your doctor tells you to.

Regular visits, blood tests and imaging help your doctors assess response and decide whether your dose of Gefticip 250 mg gefitinib should continue or be adjusted.

Precautions

Before starting Gefticip 250 mg gefitinib tablets, inform your healthcare team about your full medical history and all medicines, supplements and herbal products you use.
Key precautions include:

• Pre-existing liver disease or abnormal liver function tests
• History of interstitial lung disease, pulmonary fibrosis or chronic lung conditions
• Use of strong CYP3A4 inducers or inhibitors that may alter gefitinib blood levels
• Use of gastric acid–reducing medicines that can affect gefitinib tablet absorption
• Pregnancy or breastfeeding; Gefticip gefitinib is not recommended and may harm an unborn baby

Men and women of reproductive potential are usually advised to use reliable contraception during and for a period after Gefticip 250 mg therapy, as directed by their oncologist.

Gefitinib Side Effects

Common side effects

Common side effects of Gefticip 250 mg gefitinib tablets can include:

• Acne-like skin rash on the face, scalp and upper torso
• Dry skin, itching or mild redness
• Diarrhea or loose stools
• Nausea, occasional vomiting or reduced appetite
• Mild mouth sores or irritation in the mouth or throat
• Fatigue or low energy
• Mild elevations in liver enzymes on blood tests

These effects are often manageable with supportive care, dermatologic treatments and, when necessary, dose adjustments as decided by your oncology team.

Serious side effects

Less common but serious side effects of gefitinib require urgent medical attention and may include:

• New or rapidly worsening shortness of breath, cough and fever suggesting interstitial lung disease or severe pneumonitis
• Signs of serious liver injury: yellowing of the skin or eyes, dark urine, pale stools, persistent upper abdominal pain
• Severe or prolonged diarrhea leading to dehydration
• Severe skin reactions with blistering, peeling or painful widespread rash
• Sudden chest pain, severe breathlessness or other acute symptoms suggesting cardiovascular or pulmonary complications

If you experience any of these symptoms while taking Gefticip 250 mg, seek emergency medical care immediately and contact your oncology team.

Storage

• Store Gefticip 250 mg gefitinib tablets at room temperature, preferably below 25 °C.
• Keep tablets in their original blisters and outer carton, protected from moisture and light.
• Keep all anticancer medicines out of the sight and reach of children and pets.
• Do not use Gefticip after the expiry date printed on the packaging.

Ask your pharmacist how to safely dispose of unused or expired Gefticip gefitinib tablets.

Why Buy from Generic Meds Mart

Generic Meds Mart provides safe, structured access to key oncology medicines such as
Gefticip 250 mg gefitinib tablets at transparent prices in USD.
We source only from licensed manufacturers and authorised distributors that comply with recognised GMP standards and maintain a reliable export record.

When you buy Gefticip online from Generic Meds Mart, you benefit from:

• Original gefitinib 250 mg blisters and cartons from licensed suppliers
• Discreet, plain outer packaging for international delivery
• Tracked shipping options to many destinations
• Clear, structured information about Gefticip gefitinib tablets to support discussions with your oncology team
• Support for ordering, payment and delivery questions

Order Now

Gefticip 250 mg gefitinib tablets are prescription-only targeted anticancer medicines and must be used strictly under specialist supervision.
Before you order Gefticip online, ensure your oncologist has confirmed an EGFR-mutation–positive tumour, recommended gefitinib as part of your treatment plan and specified the daily dose and duration.

Select Gefticip 250 mg (1 pack / 30 tablets), choose the quantity that matches your written plan, add it to your cart and complete the secure checkout on Generic Meds Mart.
Your order will be processed, packed discreetly and shipped with tracking where available. All treatment decisions and dose adjustments must remain with your healthcare team.

Erlocip Erlotinib – 150 mg (1 pack / 30 tablets)

At a Glance

Brand name: Erlocip

Generic name: Erlotinib hydrochloride

Active ingredient: Erlotinib

Strength & pack size: Erlocip 150 mg (1 pack / 30 tablets)

Dosage form: Oral film-coated tablets

Main indication: Advanced or metastatic non–small cell lung cancer (NSCLC) and selected pancreatic cancer indications

Therapeutic class: EGFR tyrosine kinase inhibitor

Use in therapy: Targeted first-line or subsequent EGFR-directed therapy in NSCLC and other approved settings

Prescription status: Prescription-only anticancer medicine

Supplied by: Licensed manufacturers and authorised distributors

Storage: Store below 25 °C in a dry place, protected from moisture and light

Product Description

Erlocip 150 mg tablets are a generic erlotinib hydrochloride medicine used as targeted therapy for certain advanced cancers.
Erlotinib is an EGFR tyrosine kinase inhibitor (TKI) that interferes with signalling pathways driving tumour growth,
particularly in advanced non–small cell lung cancer (NSCLC).
Erlocip 150 mg (1 pack / 30 tablets) provides a convenient once-daily strength of erlotinib for patients whose oncologists have recommended EGFR-directed treatment.

Erlocip erlotinib tablets are often used in locally advanced or metastatic NSCLC, especially when tumours harbour activating
EGFR mutations that make them sensitive to EGFR tyrosine kinase inhibition. In some settings,
erlotinib tablets may also be used in pancreatic cancer, according to recognised protocols and specialist judgement.
Because Erlocip is a generic erlotinib product, it contains the same active ingredient as branded erlotinib while offering more accessible pricing in USD.

Each Erlocip 150 mg tablet contains erlotinib hydrochloride equivalent to 150 mg of erlotinib.
Tablets are taken by mouth, usually once daily, and your oncologist may instruct you to take Erlocip on an empty stomach or to avoid certain foods and medicines that alter absorption.
When you buy Erlocip 150 mg online from Generic Meds Mart, you receive medicines from licensed manufacturers and authorised distributors operating under recognised GMP standards.
Discreet outer packaging protects your privacy, while original blisters and cartons preserve full product information.

This Erlocip 150 mg (1 pack / 30 tablets) product is intended only for patients already under specialist oncology care who have been advised to use
erlotinib therapy. Generic Meds Mart does not diagnose cancer or change treatment plans;
the information on this page supports informed discussions with your oncology team about access to generic erlotinib tablets.

Key Uses

Erlocip 150 mg erlotinib tablets are typically used for the following indications under specialist supervision:

• Treatment of locally advanced or metastatic non–small cell lung cancer (NSCLC), especially in EGFR mutation–positive tumours
• First-line, maintenance or subsequent therapy in selected NSCLC patients where EGFR TKI treatment is recommended
• Treatment of certain advanced pancreatic cancer cases, in combination with other agents, where erlotinib is indicated

Your oncologist will determine whether Erlocip 150 mg is appropriate, specify the daily dose and decide how long
erlotinib treatment should continue.

How Erlotinib Works in Chemotherapy

Erlotinib is a targeted anticancer agent often grouped within modern systemic chemotherapy and targeted therapy regimens.
Erlocip contains erlotinib, an EGFR tyrosine kinase inhibitor (TKI) that blocks signalling from the epidermal growth factor receptor.
In many NSCLC tumours, activating EGFR mutations cause continuous signalling and uncontrolled cell growth.

Erlocip erlotinib tablets bind to the intracellular tyrosine kinase domain of EGFR and block ATP binding,
disrupting downstream signalling pathways that promote cancer cell proliferation and survival. In tumours that depend heavily on EGFR signalling,
this can lead to tumour shrinkage or stabilisation. Because erlotinib targets a molecular driver of the cancer rather than all rapidly dividing cells,
its side effect profile differs from traditional cytotoxic chemotherapy, but careful monitoring is still required.

EGFR mutation testing is an important part of deciding whether Erlocip erlotinib is appropriate.
Your oncologist will interpret test results and determine whether an EGFR TKI such as Erlocip fits your overall treatment plan.

Dosage & Administration

Erlocip 150 mg erlotinib tablets must always be taken exactly as prescribed by your oncologist.
Daily dosing, timing and duration of therapy depend on your diagnosis, tumour characteristics, other medicines and response to treatment.

• Take Erlocip tablets by mouth with water; your doctor may instruct you to take them on an empty stomach or at specific times relative to meals.
• Swallow erlotinib tablets whole without crushing, splitting or chewing unless your doctor or pharmacist provides specific instructions.
• Take Erlocip 150 mg once daily at approximately the same time each day, unless your oncologist advises otherwise.
• Do not change your dose, skip doses or stop taking Erlocip without clear guidance from your oncology team.
• If you miss a dose, follow your doctor’s instructions; do not double the next dose unless specifically advised.

Your oncologist will schedule regular visits, blood tests and imaging studies to monitor your response to
Erlocip erlotinib therapy and to adjust the treatment plan if necessary.

Precautions

Before starting Erlocip 150 mg, inform your doctor about your full medical history and all medicines, supplements or herbal products you use. Important considerations include:

• History of lung diseases such as interstitial lung disease, pulmonary fibrosis or other chronic lung conditions
• Liver disease, kidney impairment or significant cardiovascular disease
• Previous severe skin reactions or serious gastrointestinal problems
• Use of medicines that alter stomach acidity (proton pump inhibitors, H2 blockers, antacids)
• Use of CYP3A4 inhibitors or inducers, certain antibiotics, antifungals or antiepileptics that may interact with erlotinib
• Use of anticoagulants, especially warfarin, which may require closer monitoring during Erlocip erlotinib therapy

Erlotinib may not be suitable during pregnancy, and effective contraception is usually recommended during treatment and for a period afterwards, as advised by your doctor.
Breastfeeding is often discouraged while taking Erlocip. Your oncology team will explain which precautions and monitoring tests apply to you.

Erlotinib Side Effects

Common side effects

Many patients experience side effects when starting Erlocip erlotinib tablets, especially during the first weeks of therapy. Common side effects may include:

• Acne-like skin rash, often on the face, scalp or upper trunk
• Dry, itchy or sensitive skin, sometimes with increased sun sensitivity
• Diarrhea or loose stools
• Mild nausea, vomiting or stomach discomfort
• Reduced appetite and weight loss
• Fatigue or general weakness

These effects are often manageable with supportive care, skin protection, diet adjustments or dose modifications.
You should report persistent or troublesome symptoms to your oncology team.

Serious side effects

Some side effects of erlotinib are less common but serious and require urgent medical attention. Serious reactions may include:

• New or worsening shortness of breath, cough or fever that may indicate interstitial lung disease or severe lung inflammation
• Severe or persistent diarrhea with signs of dehydration, such as dizziness, fainting or reduced urine output
• Severe abdominal pain, black or bloody stools or vomiting blood, which may indicate gastrointestinal perforation or bleeding
• Signs of liver problems, including yellowing of the skin or eyes, dark urine, pale stools or intense upper abdominal pain
• Severe skin reactions with widespread rash, blistering, peeling or involvement of the mouth, eyes or other mucous membranes

If you experience any of these serious symptoms while taking Erlocip 150 mg, seek immediate medical care and contact your oncology team as soon as possible.

Storage

• Store Erlocip 150 mg tablets at room temperature, usually below 25 °C, in a dry place away from direct sunlight and excess heat.
• Keep the tablets in their original blisters and carton until use to protect them from moisture and light.
• Keep erlotinib tablets out of the sight and reach of children and pets.
• Do not use the medicine after the expiry date printed on the packaging.

Ask your pharmacist or follow local regulations for safe disposal of unused or expired Erlocip erlotinib tablets.

Why Buy from Generic Meds Mart

Generic Meds Mart focuses on providing reliable access to essential oncology medicines such as
Erlocip 150 mg erlotinib tablets at fair prices in USD.
We work only with licensed manufacturers and authorised distributors that comply with recognised GMP standards and maintain a documented export track record.

When you buy Erlocip 150 mg online from Generic Meds Mart, you benefit from:

• Competitive pricing on generic erlotinib tablets compared with many local pharmacies
• Discreet, plain packaging designed to protect your privacy during shipping
• Tracked international delivery options to many destinations
• Clear, structured product information to support discussions with your oncologist
• Customer support available to assist with ordering, payment and shipping questions

Our goal is to help you maintain continuity of prescribed targeted therapy with transparent conditions and professional handling of each order.

Order Now

Erlocip 150 mg erlotinib tablets are prescription-only anticancer medicines and must be used strictly under the supervision of an oncologist.
Before you order Erlocip 150 mg online, ensure that you have a valid prescription or written treatment plan specifying erlotinib, the 150 mg strength and the intended duration of therapy.

Select Erlocip 150 mg (1 pack / 30 tablets), choose the appropriate quantity, add Erlocip to your cart and complete the secure checkout process.
Your order will be processed, packed discreetly and shipped with tracking where available.

Generic Meds Mart does not provide diagnosis or personalised medical advice. All treatment decisions, dose changes and monitoring remain the responsibility of your oncology team.

Q6: Is Erlocip 150 mg the same as Tarceva (Generic Tarceva)?
Erlocip 150 mg is Generic Tarceva — it contains the same active ingredient (erlotinib) as Tarceva. It’s used for the same purpose at the same strength, while differences may be in manufacturer, inactive ingredients (excipients), tablet appearance, and packaging. If you’re switching between products, confirm the substitution with a qualified healthcare professional.

Armotraz 1 mg Anastrozole Tablets (1 pack / 10 pills)

At a Glance

Generic Name: Anastrozole

Product Name: Armotraz

Strength & Pack Size: 1 mg per tablet; 1 pack / 10 pills

Dosage Form & Route: Oral tablet, swallowed whole with water

Therapeutic Class: Aromatase inhibitor, endocrine (hormonal) therapy

Primary Indication: Hormone receptor–positive breast cancer in postmenopausal adults where anastrozole is appropriate

Typical Use in Therapy: Used as adjuvant endocrine therapy after surgery and/or as treatment for advanced or metastatic disease, based on specialist plan

Mode of Action: Lowers estrogen production by inhibiting aromatase, reducing hormone-driven tumour signalling

Key Benefits: Once-daily endocrine therapy option; commonly used as a Generic Arimidex alternative in specialist-led breast cancer care

Prescription Status: Prescription-only medicine

Storage: Store in original packaging, protect from moisture and heat, keep out of reach of children

Product Description

Armotraz 1 mg contains anastrozole, an aromatase inhibitor used in hormone receptor–positive breast cancer care for postmenopausal patients when a specialist determines endocrine therapy is appropriate. This medicine is widely known through searches for Generic Arimidex and generic anastrozole, because it contains the same active ingredient (anastrozole) used for the same clinical purpose under prescription-led oncology supervision. If you plan to buy Armotraz online, confirm the exact strength and treatment plan with your oncology team before ordering.

In breast cancer treatment, anastrozole is commonly used either after surgery as adjuvant endocrine therapy to reduce recurrence risk, or in advanced/metastatic settings to help control hormone-driven disease. The choice between aromatase inhibitors and other endocrine therapies depends on menopausal status, tumour receptor profile, prior treatments, bone health, comorbidities, and interaction risks. Treatment decisions are individual, and Armotraz should only be taken within a specialist-managed plan with appropriate follow-up.

Generic Meds Mart supplies Armotraz 1 mg anastrozole tablets in original manufacturer packaging sourced through licensed distribution channels. Packs typically show the product name, strength, active ingredient, batch number, and expiry date to support verification by your clinic or pharmacy. Orders are shipped in discreet outer packaging, pricing is shown in USD, and global delivery options can support continuity of therapy when your care team has already prescribed anastrozole. If you are comparing brands, do not base the decision only on anastrozole price—ask your specialist to confirm the correct product and pack size.

Key Uses

Armotraz 1 mg (anastrozole) is used in specialist-directed endocrine therapy for hormone receptor–positive breast cancer in postmenopausal patients, including adjuvant treatment after primary therapy and treatment of advanced disease where aromatase inhibition is clinically appropriate. Your oncology team defines the goal of therapy, monitoring schedule, and duration based on your overall plan.

Common Searches and Treatment Contexts for Anastrozole

Generic Arimidex: Armotraz is used as a Generic Arimidex option because both contain anastrozole for HR+ breast cancer endocrine therapy under prescription.

Anastrozole aromatase inhibitor: Anastrozole reduces estrogen production in postmenopausal patients, supporting hormone-sensitive breast cancer treatment strategies.

Anastrozole 1 mg dosage: Anastrozole dosage is defined by an oncology specialist and may require adjustments based on tolerability, interactions, and monitoring results.

Hormonotherapy for breast cancer: Aromatase inhibitors like anastrozole are core medicines in many postmenopausal endocrine therapy pathways.

Buy anastrozole online: Patients and caregivers following a prescription-led plan may seek reliable access to anastrozole tablets with verified packaging and consistent supply.

How Anastrozole Works in Breast Cancer Treatment

Anastrozole works by inhibiting the aromatase enzyme, which converts androgens into estrogen in peripheral tissues. In postmenopausal patients, this conversion is a major source of estrogen. By reducing estrogen levels, anastrozole decreases hormone stimulation of estrogen receptor–positive breast cancer cells, which can help control disease activity when used as part of a complete oncology plan.

Unlike cytotoxic chemotherapy, aromatase inhibitors act through endocrine modulation rather than direct DNA damage. Monitoring remains important because estrogen suppression can affect bone density, lipid profiles, and musculoskeletal symptoms. Your specialist balances expected benefit with risks and may recommend supportive measures and routine assessments during therapy.

Dosage & Administration

Armotraz 1 mg tablets are taken by mouth exactly as prescribed by your oncology specialist. Many regimens use once-daily dosing, but your prescriber defines the schedule, duration, and whether treatment is adjuvant or for advanced disease. Swallow tablets whole with water and take them consistently at the same time each day if your clinic advises a fixed routine.

Do not start, stop, or change anastrozole dosage on your own. If a dose is missed, follow your clinic’s instructions rather than taking extra tablets. Always share a complete list of medicines and supplements with your healthcare team, because interaction considerations and supportive care choices (including bone health medicines) are part of safe endocrine therapy planning.

Precautions

Armotraz (anastrozole) is intended for postmenopausal patients; it is not appropriate for everyone, and pregnancy must be avoided because fetal harm is possible. Discuss contraception considerations with your specialist if relevant, and do not use anastrozole during pregnancy or breastfeeding unless explicitly directed by an oncology specialist in a controlled setting.

Bone density loss and fracture risk are important considerations with aromatase inhibitors. Your clinician may monitor bone health, recommend calcium/vitamin D, lifestyle measures, or prescribe bone-protective therapy when appropriate. Joint pain, fatigue, and hot flashes can affect quality of life and should be discussed early, because supportive strategies may help adherence. Report chest pain, severe shortness of breath, signs of blood clots, or severe allergic symptoms urgently.

Anastrozole Side Effects

Common side effects

Common anastrozole side effects may include hot flashes, sweating, fatigue, headache, nausea, mild mood changes, and musculoskeletal symptoms such as joint stiffness or aches. Some patients experience vaginal dryness or reduced libido. Over time, reduced estrogen can contribute to decreased bone mineral density, which is why monitoring and prevention strategies are often part of care. If side effects affect daily functioning, speak with your oncology team rather than changing the dose independently.

Serious side effects

Serious side effects are less common but require urgent medical attention. These can include severe allergic reactions, significant liver problems (such as jaundice or dark urine), severe or worsening bone pain, fractures, or signs of cardiovascular events or blood clots (such as sudden chest pain, shortness of breath, or unilateral leg swelling). Any rapidly worsening symptoms should be assessed urgently, and clinicians should be informed that you are taking anastrozole.

Storage

Store Armotraz 1 mg in the original blister pack at room temperature, protected from moisture and excessive heat. Keep medicines out of reach of children and do not use tablets after the expiry date printed on the packaging. If your clinic provides specific storage or travel instructions, follow them carefully, especially when coordinating deliveries and follow-up appointments.

Why Buy from Generic Meds Mart

For patients seeking to manage breast cancer endocrine therapy reliably, Generic Meds Mart provides access to essential medicines like this anastrozole (Generic Arimidex) option in original packaging with verification details. We source through licensed channels and preserve original packs with batch and expiry information to support pharmacy or clinic checks.

Orders are processed in USD, shipped in discreet outer packaging, and supported with delivery options designed to help continuity of care. Generic Meds Mart does not provide personalised medical advice. Decisions about whether Armotraz is appropriate, how long to take it, and how to manage side effects must be made with qualified oncology professionals.

Order Now

Armotraz 1 mg (anastrozole) should only be used within a confirmed diagnosis and a specialist-led treatment plan for hormone receptor–positive breast cancer. Before you order Armotraz online, ensure your oncology team has confirmed the indication, treatment duration, and monitoring approach, including bone health and symptom follow-up.

Once your plan is confirmed, select Armotraz 1 mg (1 pack / 10 pills), add it to your cart, and complete secure checkout in USD. Your order will be dispatched in discreet packaging, supporting privacy during delivery. For any questions about anastrozole side effects, ongoing monitoring, or therapy changes, rely on your treating team rather than self-adjusting treatment.

FAQ about Armotraz (Anastrozole)

Q1: What is Armotraz 1 mg used for?
Armotraz 1 mg contains anastrozole, an aromatase inhibitor used in hormone receptor–positive breast cancer treatment for postmenopausal patients, including adjuvant endocrine therapy and treatment of advanced disease when prescribed by an oncology specialist.

Q2: Is Armotraz used as chemotherapy?
Armotraz is not cytotoxic chemotherapy. It is endocrine (hormonal) therapy that works by lowering estrogen levels through aromatase inhibition, and it is used under specialist supervision within a broader breast cancer treatment plan.

Q3: How is Armotraz usually taken?
Armotraz is taken by mouth as prescribed by your specialist, commonly on a once-daily schedule. Your oncology team defines the correct routine and duration, and you should not change dosing without medical guidance.

Q4: What monitoring may be needed while taking anastrozole?
Monitoring can include symptom reviews, bone health assessment, and clinical follow-up based on your individual risk factors and treatment duration. Your specialist will advise what is needed and how often.

Q5: What should I do if I experience side effects?
If you develop troublesome symptoms such as severe joint pain, significant fatigue, mood changes, or signs of serious reactions, contact your oncology team promptly. Do not stop or change therapy without professional advice.

Q6: Is Armotraz 1 mg the same as Arimidex (Generic Arimidex)?
Armotraz 1 mg is Generic Arimidex — it contains the same active ingredient (anastrozole) as Arimidex. It’s used for the same purpose at the same strength, while differences may be in manufacturer, inactive ingredients (excipients), tablet appearance, and packaging. If you’re switching between products, confirm the substitution with a qualified healthcare professional.